Kent E. Lieginger
Direktor/Vorstandsmitglied bei University of the Sciences in Philadelphia
Aktive Positionen von Kent E. Lieginger
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of the Sciences in Philadelphia | Direktor/Vorstandsmitglied | 01.01.2013 | - |
Karriereverlauf von Kent E. Lieginger
Ehemalige bekannte Positionen von Kent E. Lieginger
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2004 | 01.07.2014 |
The Genentech Foundation | Direktor/Vorstandsmitglied | 01.01.2005 | 01.01.2012 |
University of California | Corporate Officer/Principal | - | - |
GSK PLC | Corporate Officer/Principal | - | - |
ACHAOGEN | Direktor/Vorstandsmitglied | 13.03.2015 | - |
Independent Dir/Board Member | 13.03.2015 | - |
Statistik
International
Vereinigte Staaten | 6 |
Vereinigtes Königreich | 2 |
Operativ
Corporate Officer/Principal | 3 |
Director/Board Member | 3 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GSK PLC | Health Technology |
Private Unternehmen | 3 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
The Genentech Foundation | Miscellaneous |
- Börse
- Insiders
- Kent E. Lieginger
- Erfahrung